
|Articles|May 10, 2004
Sacral stimulation: Improvements in QoL fade over the long term
Although quality of life improves significantly 6 months after treatmentwith sacral neuromodulation for voiding dysfunction, the reported qualityof life indicators are not statistically significant in the long term. However,not even the mitigation of symptoms is enough to keep patients happy overtime, said Anurag K. Das, MD, during a presentation at the AUA meeting Sunday.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5















